Facts of Kadcyla ( Ado-Trastuzumab emtansine ) ?

  • Medicine Name: Kadcyla
  • Date of Approval: 22.02.2013
  • Company Name: Genentech.

What is Kadcyla ( Ado-Trastuzumab emtansine ) ?

Kadcyla contains the active substance trastuzumab emtansine, which is made up of two parts that are linked together:

  • trastuzumab - a monoclonal antibody that binds selectively to an antigen (a target protein) called human epidermal growth factor receptor 2 (HER2). HER2 is found in large amounts on the surface of some cancer cells where it stimulates their growth. When trastuzumab binds to HER2 it can stop the cancer cells growth and cause them to die.
  • DM1 – an anti-cancer substance that becomes active once Kadcyla enters the cancer cell.

Quote From European Medicines Agency website: www.ema.europa.eu

What are the indications and usage?

Kadcyla is used to treat breast cancer in adults when:

  • the cancer cells have many HER2 proteins on them - your doctor will test your cancer cells for this.

  • you have already received the medicine trastuzumab and a medicine known as a taxane.

  • the cancer has spread to areas near the breast or to other parts of your body

  • Quote From European Medicines Agency website: www.ema.europa.eu

Innovator Brands Available

KADCYLA Ado-Trastuzumab Emtansine 160mg for Injection

KADCYLA Brochure

Contact Details

IKRIS Pharma Network Pvt. Ltd.
905 , I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120–2400370.
M: + 91 8130290915

Query Form

What is the best price of Kadcyla ( Ado-Trastuzumab emtansine ) ?

Please contact +91 8130290915 for price of KADCYLA in India

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Where can I Buy Kadcyla ( Ado-Trastuzumab emtansine ) ?

IKRIS PHARMA NETWORK connects buyer with the supplier who can ship Kadcyla (Cancer Treatment Medicines) to any country of the world as per the buyer's requirement and Government regulations of the country. Kadcyla is manufactured by Genentech

IKRIS PHARMA NETWORK provides options of choosing exporter and supplier of Cancer treatment Medicines

Is Kadcyla available in India?

Kadcyla is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IKRIS Pharma Network facilitates import of cancer medicines on the named patient supply. IKRIS Pharma Network is facilitator providing input

  • On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
  • Medicine Price.
  • Finding Genuine and reliable source from Canada, Europe, USA and Australia
  • Ensuring 100% transparency.

Kadcyla can be made available Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India"

IKRIS Pharma Network can facilitate the supply of Kadcyla (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

How order will be confirmed ?

The order will be confirmed only after the receipt of

  1. Valid prescription of Clinician
  2. Import permit if applicable

Send your enquiry to find the

Cost of Kadcyla ( Ado-Trastuzumab emtansine ) in Australia, Brazil, China, Canada, Eqypt, Europe, France, Germany, Hongkong, India, Iran, Italy, Mexico, Pakistan, Poland, Spain, Singapore, Thailand, Russia, Romania, UK, Middle East, UAE, Ukraine.


General disclaimer under Facts and usage:
Please note that all information in relation to this drug is of general nature and may not be applicable to your specific situation and circumstance. Any information available here is not a substitute for professional medical advice by a licensed practitioner. We will help you in importing this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present.

General disclaimer under where can I buy the medicine/is the medicine available in India:
Please note that Ikris Pharma Network is a consultancy company, which facilitates patients, hospitals, clinicians and researchers in accessing products, which are not available or approved in their home country. Ikris Pharma Network has no relation whatsoever with this medicine including but not limited to being its manufacturer, seller, reseller, distributor, agent or licensee. Ikris Pharma will not purchase this medicine but will only assist you in doing so against a valid prescription and other documents as required by the laws of the jurisdiction in which you are present. None of the trademarks and other intellectual property and proprietary marks of this medicine belong to or are claimed to belong to the Ikris Pharma Network.